A Gene Expression Signature that Predicts Gastric Cancer Sensitivity to PARP Inhibitor Therapy. Fujiya K, Serizawa M, Ohshima K, Umehara R, et al. Anticancer Res 2024;44:4779-4788.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Fujiya K, Serizawa M, Ohshima K, Umehara R, et al. A Gene Expression Signature that Predicts Gastric Cancer Sensitivity to PARP Inhibitor Therapy. Anticancer Res 2024;44:4779-4788.
PMID: 39477296